Pacira BioSciences (PCRX) Other Non-Current Assets (2010 - 2019)

Pacira BioSciences' (PCRX) quarterly Other Non-Current Assets came in at $560000.0 in Q1 2019, down 26.22% year-on-year from $759000.0 in Q1 2018, and down 14.76% quarter-over-quarter from $657000.0 in Q4 2018.

Pacira BioSciences (PCRX) Other Non-Current Assets (2010 - 2019) Analysis & Trends

Pacira BioSciences' Other Non-Current Assets history runs 10 years deep, the most recent figure standing at $560000.0 for Q1 2019.

  • On a quarterly basis, Other Non-Current Assets fell 26.22% year-over-year to $560000.0 in Q1 2019; TTM through Mar 2019 was $560000.0, a 26.22% decrease from a year earlier, with the FY2018 full-year figure at $657000.0, down 20.36% from the prior year.
  • Other Non-Current Assets fell to $560000.0 in Q1 2019 per PCRX's latest filing, from $657000.0 in the prior quarter.
  • Across five years, Other Non-Current Assets topped out at $2.6 million in Q3 2015 and bottomed at $406000.0 in Q4 2015.
  • The 5-year median for Other Non-Current Assets is $657000.0 (2018), against an average of $945470.6.
  • Across the five-year window, Other Non-Current Assets tumbled 84.31% in 2015 and surged 53.69% in 2016, its largest moves.
  • Year by year, Other Non-Current Assets stood at $406000.0 in 2015, then soared by 53.69% to $624000.0 in 2016, then jumped by 32.21% to $825000.0 in 2017, then decreased by 20.36% to $657000.0 in 2018, then decreased by 14.76% to $560000.0 in 2019.
  • Per Business Quant, the three latest PCRX Other Non-Current Assets figures stand at $560000.0 (Q1 2019), $657000.0 (Q4 2018), and $747000.0 (Q3 2018).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - 49.22 Mn
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn 1.79 Bn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn 351.00 Mn
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn 491.06 Mn
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn 233.20 Mn
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn 1.11 Bn
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn 73.60 Mn
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn 295.00 Mn
10 Pacira BioSciences 1.05 Bn 846.97 Mn 140.96 Mn -

Historic Data

Download Data
DateValue
Mar 31, 2019 560,000.00
Dec 31, 2018 657,000.00
Sep 30, 2018 747,000.00
Jun 30, 2018 692,000.00
Mar 31, 2018 759,000.00
Dec 31, 2017 825,000.00
Sep 30, 2017 545,000.00
Jun 30, 2017 572,000.00
Mar 31, 2017 598,000.00
Dec 31, 2016 624,000.00
Sep 30, 2016 651,000.00
Jun 30, 2016 677,000.00
Mar 31, 2016 481,000.00
Dec 31, 2015 406,000.00
Sep 30, 2015 2.60 Mn
Jun 30, 2015 2.25 Mn
Mar 31, 2015 2.43 Mn
Dec 31, 2014 2.59 Mn
Sep 30, 2014 2.95 Mn
Jun 30, 2014 3.10 Mn